Literature DB >> 1866855

Identifying risk factors in development of clinically significant post-shock-wave lithotripsy subcapsular hematomas.

L H Newman1, B Saltzman.   

Abstract

A retrospective study of 1,012 shock-wave lithotripsy treatments was performed to identify and analyze the risk factors for the development of six clinically significant post-extracorporeal shock-wave lithotripsy (ESWL) subcapsular hematomas. The patients studied had clinical signs and symptoms that on evaluation were confirmed as originating from a subcapsular hematoma. Common factors identified which we believe may put patients at increased risk for the development of subcapsular hematoma included hypertension, diabetes mellitus, coronary artery disease, and obesity.

Entities:  

Mesh:

Year:  1991        PMID: 1866855     DOI: 10.1016/0090-4295(91)80009-v

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  12 in total

Review 1.  The acute and long-term adverse effects of shock wave lithotripsy.

Authors:  James A McAteer; Andrew P Evan
Journal:  Semin Nephrol       Date:  2008-03       Impact factor: 5.299

2.  Shock wave lithotripsy and renal hemorrhage.

Authors:  Jonathan Silberstein; Charles M Lakin; J Kellogg Parsons
Journal:  Rev Urol       Date:  2008

3.  Shock wave lithotripsy in patients requiring anticoagulation or antiplatelet agents.

Authors:  Bader Alsaikhan; Sero Andonian
Journal:  Can Urol Assoc J       Date:  2011-02       Impact factor: 1.862

4.  Scrotal bruising as a sign of retroperitoneal haematoma following extracorporeal shock wave lithotripsy.

Authors:  H Biri; Z Sinik; T Alkibay; U Karaoğlan; I Bozkirli
Journal:  Int Urol Nephrol       Date:  1997       Impact factor: 2.370

5.  Influence of acetylsalicylic acid and low-molecular weight heparins on the formation of renal hematoma after shock wave lithotripsy.

Authors:  Christoph Schregel; Hubert John; Marco Randazzo; Isabelle Keller
Journal:  World J Urol       Date:  2017-07-12       Impact factor: 4.226

6.  Incidence and risk factors of renal hematoma: a prospective study of 1,300 SWL treatments.

Authors:  M J Schnabel; M Gierth; C G Chaussy; K Dötzer; M Burger; H M Fritsche
Journal:  Urolithiasis       Date:  2014-01-14       Impact factor: 3.436

7.  Is shock wave lithotripsy efficient for the elderly stone formers? Results of a matched-pair analysis.

Authors:  Prodromos Philippou; Djelali Lamrani; Konstantinos Moraitis; Christian Bach; Junaid Masood; Noor Buchholz
Journal:  Urol Res       Date:  2011-09-08

8.  A low or high BMI is a risk factor for renal hematoma after extracorporeal shock wave lithotripsy for kidney stones.

Authors:  Fabio Nussberger; Beat Roth; Tobias Metzger; Bernhard Kiss; George N Thalmann; Roland Seiler
Journal:  Urolithiasis       Date:  2016-08-30       Impact factor: 3.436

9.  Treatment of upper urinary tract stones with extracorporeal shock wave lithotripsy (ESWL) Sonolith vision.

Authors:  Kogenta Nakamura; Motoi Tobiume; Masahiro Narushima; Takahiko Yoshizawa; Genya Nishikawa; Yoshiharu Kato; Remi Katsuda; Kenji Zennami; Shigeyuki Aoki; Yoshiaki Yamada; Nobuaki Honda; Makoto Sumitomo
Journal:  BMC Urol       Date:  2011-12-12       Impact factor: 2.264

10.  Shock-wave lithotripsy in the elderly: Safety, efficacy and special considerations.

Authors:  Prodromos Philippou; D Lamrani; Konstantinos Moraitis; Hassan Wazait; Junaid Masood; Noor Buchholz
Journal:  Arab J Urol       Date:  2011-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.